Aldebaran Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.4M	Sell	217,827 -41,426	-16%	-$266K	1.38%	19
2025 Q1	$918K	Sell	259,253 -3,500	-1%	-$12.4K	0.87%	23
2024 Q4	$993K	Sell	262,753 -7,050	-3%	-$26.6K	0.94%	23
2024 Q3	$874K	Hold	269,803	–	–	0.8%	24
2024 Q2	$513K	Buy	+269,803	New	+$513K	0.48%	27